Showing 5,981 - 6,000 results of 9,864 for search '"drug"', query time: 0.09s Refine Results
  1. 5981

    A randomized controlled trial: Effects of compression therapy combined with exercise on chemotherapy-induced peripheral neuropathy in patients with breast cancer by Yu Xiaoqian, Hu Jiwei, Zhou Lizhi, Guo Baojia, Guo Luyan, Xu Huiqian, Li Hong, Fan Yijing

    Published 2024-01-01
    “…The National Institute of Cancer Drug Toxicity Rating Scale and the Chemotherapy-Induced Peripheral Neuropathy Assessment Tool were assessed and compared between groups. …”
    Get full text
    Article
  2. 5982

    Screening of Active Components and Key Targets of Radix Codonopsis in the Treatment of Gastric Cancer by Lijun Tang, Jinhui Chen, Jin Yin, Mingli Fang

    Published 2021-01-01
    “…At the same time, chemotherapy drugs can make patients develop drug resistance and seriously affect the curative effect. …”
    Get full text
    Article
  3. 5983

    Cardioprotective effects of hUCMSCs-Exosi-EGR1 MN patch in MI/RI by modulating oxidative stress and mitophagy by Chen Huang, Xun Zhang, Shi-Xiong Wu, Qing Chang, Zhi-Kun Zheng, Jing Xu

    Published 2025-04-01
    “…Moreover, the Exosi-EGR1 MN patch exhibited excellent mechanical properties and sustained drug release characteristics when embedded in a Gelatin methacryloyl (GelMA) matrix. …”
    Get full text
    Article
  4. 5984
  5. 5985

    Molecular docking of ferulic acid, bakuchiol and niazirin on peroxisome proliferator-activated receptor gamma (PPAR-γ) as anti-diabetic agents by Anjar Hermadi Saputro, Riri Fauziyya, Sarmoko, Iwan Syahjoko Saputra

    Published 2024-08-01
    “…The analysis focused on binding free energy values, amino acid residue interactions, the number of hydrogen bonds, and bond distances, comparing these results to those of the native ligand and pioglitazone, a known anti-diabetic drug targeting PPAR-γ. Results: The binding free energies for the ferulic acid-PPAR-γ, bakuchiol-PPAR-γ, niazirin-PPAR-γ, native ligand-PPAR-γ, and pioglitazone-PPAR-γ complexes were -5.54 kcal/mol, -8.47 kcal/mol, -6.56 kcal/mol, -10.08 kcal/mol, and -9.94 kcal/mol, respectively. …”
    Get full text
    Article
  6. 5986

    Implementation and Evaluation of a Long-Term Care at Home (Home LTC) Service in a Rural Community Pharmacy Setting by Megan Ditzman, Stevie Veach, Jessie Schaefer, Kaitlin Luett, Bryan Kendall, Matthew Witry

    Published 2025-02-01
    “…The objectives were to: 1) describe implementation and challenges of pharmacy-provided HOME LTC services, 2) attempt billing for Home LTC services, 3) describe pharmacist clinical interventions including drug therapy problems (DTPs) and 4) measure patient/caregiver satisfaction with the service. …”
    Get full text
    Article
  7. 5987

    Enhanced Regeneration and Hepatoprotective Effects of Interleukin 22 Fusion Protein on a Predamaged Liver Undergoing Partial Hepatectomy by Heng Zhou, Guomin Xie, Yudi Mao, Ke Zhou, Ruixue Ren, Qihong Zhao, Hua Wang, Shi Yin

    Published 2018-01-01
    “…Our study suggests that IL-22-FP may represent a promising therapeutic drug against regeneration deficiency and liver IRI in patients who have undergone PHx.…”
    Get full text
    Article
  8. 5988

    Effect of Candida albicans’ supernatant on biofilm formation and virulence factors of Pseudomonas aeruginosa through las/rhl System by Ke Zhang, Yingying Huang, Yuting Jiang, Tangjuan Liu, Jinliang Kong, Shuangqi Cai, Zhongwei Wen, Yiqiang Chen

    Published 2025-02-01
    “…Abstract Pseudomonas aeruginosa (P. aeruginosa) and Candida albicans (C. albicans) are opportunistic pathogens whose mixed infections can exacerbate microbial dissemination and drug resistance, contributing to high mortality and morbidity rates among infected individuals. …”
    Get full text
    Article
  9. 5989

    Cuban medical students’headache in relation to factors associated with academic stress by Annier Jesús Fajardo Quesada, María de los Ángeles Licea González, Fidel Jesús Moreno Cubela, Eduardo Adiel Landrove Escalona, Yudier Brizuela Fernández

    Published 2023-02-01
    “…The variables age, sex, academic year, presence of associated disease, frequency per week, average hours of sleep per day, frequency variation (during oral exams, written exams, medical shifts, high extracurricular demands, days off), average pain intensity, most frequent onset time, duration, most commonly used drugs, and use of pain-relieving drugs were studied.…”
    Get full text
    Article
  10. 5990

    Threat to fish food safety in Nigeria: Role of antimicrobial usage and resistance in aquaculture by Lukman Adegoke Agbabiaka, Favour Ogechi Onwuzuruigbo, Olatunji Abubakar Jimoh

    Published 2025-03-01
    “…Despite widespread AMR awareness (66 %), only 57.5 % followed drug leaflet prescriptions, while 80 % administered drugs without disease outbreak. …”
    Get full text
    Article
  11. 5991

    Programmed polymeric integration of gold nanoparticles into multi-material 3D printed hydrogels by Said El Turk, Dileep Chekkaramkodi, Murad Ali, Abdulrahim A. Sajini, Haider Butt

    Published 2025-02-01
    “…They are utilized for targeted drug delivery, biological sensing, antimicrobial systems, and for plasmonic optical devices. …”
    Get full text
    Article
  12. 5992
  13. 5993

    Development and Validation of a GC-MS Method for the Detection and Quantification of Clotiapine in Blood and Urine Specimens and Application to a Postmortem Case by Giulio Mannocchi, Flaminia Pantano, Roberta Tittarelli, Miriam Catanese, Federica Umani Ronchi, Francesco Paolo Busardò

    Published 2015-01-01
    “…There is little published data on the therapeutic and toxic concentrations of this drug. Aims. The aim of the present study is the development and validation of a method that allows the detection and quantification of clotiapine in blood and urine specimens by gas chromatography-mass spectrometry (GC-MS). …”
    Get full text
    Article
  14. 5994

    The Krushinsky – Molodkina genetic rat strain as a unique experimental model of seizure states by I. I. Poletaeva, Z. A. Kostyna, N. M. Surina, I. B. Fedotova, Z. A. Zorina

    Published 2017-07-01
    “…In spite of numerous anticonvulsant drugs a significant proportion of epilepsy cases are still resistant to drug treatments. …”
    Get full text
    Article
  15. 5995
  16. 5996
  17. 5997

    Measles neutralising antibody levels in patients receiving intravenous immunoglobulin treatment - a sub-analysis of a randomized, cross-over bioequivalence trial. by Vatsala Rajendram, Martyn Paddick, John More

    Published 2025-01-01
    “…Each batch of intravenous immunoglobulin is required by the Food and Drug Administration to contain threshold levels of measles neutralising antibodies. …”
    Get full text
    Article
  18. 5998

    Therapeutic Potential of Liraglutide for Diabetes–Periodontitis Comorbidity: Killing Two Birds with One Stone by Man Yang, Yunqing Pang, Minyu Pei, Yuanyuan Li, Xuemin Yuan, Rongbing Tang, Jing Wang

    Published 2022-01-01
    “…There is a quest for a drug that can be used to treat both conditions simultaneously. …”
    Get full text
    Article
  19. 5999

    A Literature Review Determinat Factors of Quality of Life in Chronic Kidney Disease patients with Hemodialysis by Ni Wayan Sri Wahyuni, Ni Putu Kamaryati, Made Rismawan, Putu Inge Ruth Suantika

    Published 2025-02-01
    “…Results: From the literature review, it was found that some of the factors studied were demographic factors such as age, gender, education, hemodialysis duration, medication adherence, depression, complications, family support, income, nutritional status, hemoglobin levels, and comorbidities.Conclusion: From the results of the above study, several factors affect the quality of life of hemodialysis patients, namely the duration of hemodialysis, drug compliance, age, gender, education, occupation, gender, family support, nutritional status, depression, hemoglobin levels and comorbidities. …”
    Get full text
    Article
  20. 6000

    Sinusoidal Obstruction Syndrome (SOS) in Multiple Myeloma with Renal Failure by Urvi A. Shah, Sengottuvel Viswanathan, Beamon Agarwal, Aditi Shastri, Ioannis Mantzaris, Murali Janakiram, Noah Kornblum, Ira Braunschweig, Amit Verma, Yang Shi, John Reinus, Olga Derman

    Published 2018-01-01
    “…Although, melphalan and cyclophosphamide cause SOS less commonly than alkylating agents such as busulfan, physicians must use caution when administering these drugs to patients with underlying comorbidities such as renal failure that may increase the likelihood of development of SOS. …”
    Get full text
    Article